A pilot study of 220 mg/m2 melphalan followed by autologous stem cell transplantation in patients with advanced haematological malignancies: Pharmacokinetics and toxicity

British Journal of Haematology

Volumn 95, Issue 3, 1996, Pages 527-530

  Moreau, Philippe ^a,b   Kergueris, Marie France ^a   Milpied, Noël ^a   Le Tortorec, Stéphane ^a   Mahé, Béatrice ^a   Bulabois, Claude Eric ^a   Rapp, Marie José ^a   Larousse, Claude ^a   Bataille, Régis ^a   Harousseau, Jean Luc ^a  

^a Department of Haematology ^*  (France)

^b HÔTEL DIEU   (France)

Author keywords

High dose; Melphalan; Multiple myeloma; Pharmacokinetics

Indexed keywords

MELPHALAN;

ADVANCED CANCER; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; PRIORITY JOURNAL;

EID: 12644264334     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1932.x     Document Type: Article

References (12)

1. Ardiet, C., Tranchand, B., Biron, P., Rebattu, P. & Philip, T. (1986) Pharmacokinetics of high-dose intravenous melphalan in children and adults with forced diuresis. Cancer Chemotherapy and Pharmacology, 16, 300-305.
2. Bensinger, W.I., Longin, K., Appelbaum, F., Rowley, S., Weaver, C., Lilleby, K., Gooley, T., Lynch, M., Higano, T., Klarnet, J., Chauncey, T., Storb, R. & Buckner, C.D. (1994) Peripheral blood stem cells collected after recombinant granulocyte colony stimulating factor: an analysis of factors correlating with the tempo of engraftment after transplantation. British Journal of Haematology, 87, 825-831.
3. Cunningham, D., Paz-Ares, L., Milan, S., Powles, R., Nicolson, M., Hickish, T., Selby, P., Treleaven, J., Viner, C., Malpas, J., Slevin, M., Findlay, M., Raymond, J. & Gore, M.E. (1994) High-close melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma. Journal of Clinical Oncology, 12, 759-763.
4. Gore, M.E., Selby, P.J., Viner, C., Clark, P.L., Meldrum, M., Millar, B., Bell, J., Maitland, J.A., Milan, S., Judson, I.R., Zuiable, A., Tillyer, C., Slevin, M., Malpas, J.S. & McElwain, T.J. (1989) Intensive treatment of multiple myeloma and criteria for complete remission. Lancet. ii, 879-882.
5. Gouyette, A., Hartman, O. & Pico, J.L. (1986) Pharmacokinetics of high-dose melphalan in children and adults. Cancer Chemotherapy and Pharmacology, 16, 184-189.
6. Kergueris, M.F., Milpied, N., Moreau, P., Harrousseau, J.L. & Larousse, C. (1994) Pharmacokinetics of high-dose melphalan in adults: influence of renal function. Proceedings of the 5th Conference on Oncological Clinical Pharmacology, Reims, Anticancer Research, 14, 2378-2382.
7. Moreau, P., Kergueris, M.F., Milpied, N., Larousse, C., Bataille, R. & Harousseau, J.L. (1995) Pharmacokinetics of high-dose melphalan in 50 adults with hematological malignancies. (Abstract). Vth International Workshop on Multiple Myeloma, La Baule, France.
8. Prince, H.M., Imrie, K., Sutherland, D.R., Keating, A., Meharchand, J., Crump, R.M., Girouard, C., Trip, K. & Stewart, A.K. (1996) Peripheral blood progenitor cell collections in multiple myeloma: predictors of management of inadequate collections. British Journal of Haematology, 93, 142-145.
9. Reece, P.A., Hill, H.S., Green, R.M., Morris, R.G., Dale, B.M., Kotasek, D. & Sage, R.E. (1988) Renal clearance and protein binding of melphalan in patients with cancer. Cancer Chemotherapy and Pharmacology, 22, 348-852.
10. Samuels, B.L. & Bitran, J.D. (1995) High-dose intravenous melphalan: a review. Journal of Clinical Oncology, 13, 1786-1799.
11. Selby, P.J., McElwain, T.J. & Nandi, A.C. (1987) Multiple myeloma treated with high-dose intravenous melphalan. British Journal of Haematology, 66, 55-61.
12. Taha, I.A.K., Ahmad, R.A., Rogers, D.W., Pritchard, J. & Rogers, H.J. (1983) Pharmacokinetics of melphalan in children following high-dose intravenous injections. Cancer Chemotherapy and Pharmacology, 10, 212-216.